| Title | Date | PubMed ID |
|---|
| ADAMTS-4 activity in synovial fluid as a biomarker of inflammation and effusion. | 2015 Sep | 26003949 |
| Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis. | 2014 Dec 26 | 25415648 |
| Matrilin-2 is proteolytically cleaved by ADAMTS-4 and ADAMTS-5. | 2014 Jun 23 | 24959676 |
| ADAMTS-4 and biglycan are expressed at high levels and co-localize to podosomes during endothelial cell tubulogenesis in vitro. | 2014 Jan | 24051360 |
| ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice. | 2013 Jul 15 | 23319426 |
| Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma. | 2013 Apr | 23131589 |
| The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. | 2012 Mar 15 | 22420304 |
| Anti-angiogenic properties of ADAMTS-4 in vitro. | 2012 Feb | 22264287 |
| Mechanisms involved in enhancement of the expression and function of aggrecanases by hyaluronan oligosaccharides. | 2012 Jan | 21905012 |
| ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. | 2011 Dec | 21815191 |